As of 2024-12-12, the Intrinsic Value of Genovis AB (GENO.ST) is
23.24 SEK. This GENO.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 25.30 SEK, the upside of Genovis AB is
-8.10%.
The range of the Intrinsic Value is 16.06 - 45.28 SEK
23.24 SEK
Intrinsic Value
GENO.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
16.06 - 45.28 |
23.24 |
-8.1% |
| DCF (Growth 10y) |
31.17 - 90.29 |
45.75 |
80.8% |
| DCF (EBITDA 5y) |
21.96 - 43.23 |
34.17 |
35.1% |
| DCF (EBITDA 10y) |
38.05 - 78.43 |
59.78 |
136.3% |
| Fair Value |
6.59 - 6.59 |
6.59 |
-73.96% |
| P/E |
6.35 - 25.30 |
13.74 |
-45.7% |
| EV/EBITDA |
7.74 - 20.90 |
13.44 |
-46.9% |
| EPV |
6.78 - 9.42 |
8.10 |
-68.0% |
| DDM - Stable |
3.05 - 11.18 |
7.11 |
-71.9% |
| DDM - Multi |
16.95 - 48.46 |
25.13 |
-0.7% |
GENO.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,656.28 |
| Beta |
0.72 |
| Outstanding shares (mil) |
65.47 |
| Enterprise Value (mil) |
1,597.98 |
| Market risk premium |
5.10% |
| Cost of Equity |
6.09% |
| Cost of Debt |
10.29% |
| WACC |
6.19% |